SCHEMBL14939766

SCHEMBL14939766

COc1cncc(C2C(=O)c3ccccc3C2=O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.61
TP53 P04637 3/20 0.61
MAPT P10636 3/20 0.61
NPC1 O15118 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
HPGD P15428 2/20 0.61
MAOA P21397 1/20 0.61
PTGS2 P35354 1/20 0.61
MAPK10 P53779 1/20 0.53
GAA P10253 3/20 0.53
NPSR1 Q6W5P4 1/20 0.53
KMT2A Q03164 5/20 0.52
MEN1 O00255 4/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPK1 P28482 1/20 0.46
HTR2B P41595 1/20 0.46
CYP19A1 P11511 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14939328 0.82 RAB9A (0.71) RAB9ATP53MAPTNPC1SMN1; SMN2
SCHEMBL8958196 0.79 RAB9A (0.67) RAB9ATP53MAPTNPC1SMN1; SMN2
Anisindione SCHEMBL49379 0.76 RAB9A (1.00) RAB9ATP53MAPTNPC1SMN1; SMN2
Anisindione SCHEMBL29688105 0.76 RAB9A (1.00) RAB9ATP53MAPTNPC1SMN1; SMN2
SCHEMBL14939354 0.76 RAB9A (0.63) RAB9ATP53MAPTNPC1SMN1; SMN2
SCHEMBL14939144 0.76 RAB9A (0.53) RAB9ATP53MAPTNPC1SMN1; SMN2
SCHEMBL14939218 0.75 RAB9A (0.61) RAB9ATP53MAPTNPC1SMN1; SMN2
SCHEMBL14939515 0.72 RAB9A (0.49) RAB9ATP53MAPTNPC1SMN1; SMN2
SCHEMBL855370 0.70 RAB9A (1.00) RAB9ATP53MAPTNPC1SMN1; SMN2
SCHEMBL14940174 0.69 MAPT (0.63) RAB9ATP53MAPTNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013068785-A1 INDANONE AND INDANDIONE DERIVATIVES AND HETEROCYCLIC ANALOGS ACTELION PHARMACEUTICALS LTD (CH) 2013-05-16 WO disclosed